Together, these findings demonstrate that KIT-d-MMAE preferentially accumulates and persists in tumor tissue, while being rapidly cleared from circulation and normal organs, suggesting its potential for effective and low-toxicity targeted therapy. The gene discussed is KIT; the disease is neoplasm.